Medication info
Bonel Tablet 35 mg (Risedronate Sodium 2.5 Hydrate)

Bonel Tablet 35 mg (Risedronate Sodium 2.5 Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Risedronate Sodium 2.5 Hydrate›40.17mg / 1 tablet
Manufacturer / importer
Myeongmun Pharmaceutical Co., Ltd.
Appearance
Pale orange rectangular film-coated tablets
Packaging
4 tablets (4 tablets/PTP X 1)
Approval status
Active

MFDS item code 200713910 · Notified 2007.12.31 · Insurance code 649804340

Summary

Main use
Treatment and prevention of osteoporosis in postmenopausal women; treatment of osteoporosis in men
Who takes it
Adults · Children
Adult dose
Adults: Administer 35 mg of risedronate sodium orally once weekly. Older adults: No dosage adjustment is necessary in older adults (over 60 years of age), since the bioavailability and pharmacodynamics of this drug are similar to those in younger people. Patients with renal impairment: No dosage adjustment is necessary in patients with a creatinine clearance of 30 mL/min or greater. This drug is contraindicated in patients with severe renal impairment and a creatinine clearance below 30 mL/min. Food interferes with the absorption of this drug. To ensure adequate absorption, take it at least 30 minutes before breakfast, or at any time of day at least 2 hours before or after consuming food or beverages. To help this drug reach the stomach easily and reduce the possibility of esophageal irritation, take it in an upright position with a sufficient amount of plain water (170 ∼ 230 mL). Taking it with other beverages, including mineral water, may reduce absorption of this drug. Do not chew or suck this drug because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking it. If a patient forgets to take a dose on the scheduled dosing day, take it the next morning when remembered. Take the next dose on the originally scheduled dosing day. Do not take 2 tablets on the same day.
Child dose
Children under 18 years of age: Safety and efficacy have not been established.

Ingredients

Manufacturer
Myeongmun Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment and prevention of osteoporosis in postmenopausal women; treatment of osteoporosis in men

  • Osteoporosis
View approved original text

This tablet is used for the treatment and prevention of osteoporosis in postmenopausal women and men.

How to take

Adult dose

Adults: Administer 35 mg of risedronate sodium orally once weekly. Older adults: No dosage adjustment is necessary in older adults (over 60 years of age), since the bioavailability and pharmacodynamics of this drug are similar to those in younger people. Patients with renal impairment: No dosage adjustment is necessary in patients with a creatinine clearance of 30 mL/min or greater. This drug is contraindicated in patients with severe renal impairment and a creatinine clearance below 30 mL/min. Food interferes with the absorption of this drug. To ensure adequate absorption, take it at least 30 minutes before breakfast, or at any time of day at least 2 hours before or after consuming food or beverages. To help this drug reach the stomach easily and reduce the possibility of esophageal irritation, take it in an upright position with a sufficient amount of plain water (170 ∼ 230 mL). Taking it with other beverages, including mineral water, may reduce absorption of this drug. Do not chew or suck this drug because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking it. If a patient forgets to take a dose on the scheduled dosing day, take it the next morning when remembered. Take the next dose on the originally scheduled dosing day. Do not take 2 tablets on the same day.

Child dose

Children under 18 years of age: Safety and efficacy have not been established.

Precautions

This medication may irritate the gastric mucosa, so anyone with esophageal or gastric disorders should consult a doctor before use. Special caution is needed for patients with Barrett's esophagus, dysphagia, esophageal diseases, gastritis, duodenitis, or ulcers. After ingestion, do not lie down for at least 30 minutes and take the medication with a sufficient amount of water while maintaining an upright posture. Serious side effects such as esophagitis or esophageal ulcers may occur rarely; therefore, if symptoms such as dysphagia, chest pain, or heartburn appear, immediately discontinue use and consult a healthcare professional. Patients with esophageal motility disorders, hypocalcemia, pregnant or breastfeeding women, and those with severe renal dysfunction should not take this medication. Patients with a genetic condition that prevents the breakdown of lactose should also avoid this medication. During the use of this drug, it is important to ensure adequate calcium and vitamin D intake, and supplementation may be needed for those undergoing long-term corticosteroid treatment. Bisphosphonate medications can cause rare side effects such as osteonecrosis of the jaw or atypical fractures; thus, oral hygiene and regular dental check-ups are necessary. When taken with other drugs, absorption may be affected, particularly those containing calcium, magnesium, or iron, so a gap of at least 2 hours should be maintained between doses. Pregnant and breastfeeding women should avoid using this medication and consult a doctor if necessary. Safety in children under 18 years has not been established, so use is not recommended. Overdose may lead to hypocalcemia; if symptoms occur, visit a medical facility immediately and calcium supplementation treatment may be administered if needed. This medication should be kept out of the reach of children, and it's important not to transfer it to other containers to maintain quality.

Side effects

  • Esophagitis
  • esophageal ulcer
  • esophageal erosion
  • esophageal obstruction
  • esophageal perforation
  • hemorrhage
  • dyspepsia
  • diarrhea
  • abdominal pain
  • nausea
Show 50 more
  • peripheral edema
  • arthralgia
  • arthritis
  • bone trauma
  • joint abnormalities
  • myalgia
  • bone pain
  • dizziness
  • depression
  • insomnia
  • bronchitis
  • sinusitis
  • rhinitis
  • pharyngitis
  • increased cough
  • rash
  • cataract
  • urinary tract infection
  • mucous membrane syndrome
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • angioedema
  • blisters
  • skin reactions
  • bone pain
  • musculoskeletal pain
  • external auditory canal osteonecrosis
  • iritis
  • uveitis
  • liver dysfunction
  • jaundice
  • loss of appetite
  • asthenia
  • heartburn
  • epigastric pain
  • chest discomfort
  • palpitations
  • increased sweating
  • facial flushing
  • warmth sensation
  • kidney stones
  • belching
  • hematuria
  • fever
  • eye pain
  • acute phase reaction
  • vomiting
  • hypocalcemia
  • signs and symptoms of hypocalcemia
  • hypocalcemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air or moisture from entering, and it is advisable to keep it at room temperature that is not too hot or too cold. Proper storage will help maintain the efficacy of the drug for a longer period.

Appearance and packaging

Appearance

Pale orange rectangular film-coated tablets

Package unit

4 tablets (4 tablets/PTP X 1)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.